Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Intra-Cellular Therapies Inc. (ITCI)

« Back to company index

ITCI Chatter Timeline

Stock Ticker for ITCI

Most Active Tweeters for ITCI

UserTweets
@AmericanBanking 4
@TickerReport 4
@stocknewstimes 4
@Tickeron 3
@TranscriptDaily 3

Recent Tweets for ITCI

WeekHerald @WeekHerald
Intra-Cellular Therapies $ITCI Given a $21.00 Price Target at JMP Securities https://t.co/aFhboKGchc
September 14th 2019, 7:09pm
OlympiaReport @OlympiaReport
Intra-Cellular Therapies $ITCI Given a $21.00 Price Target at JMP Securities https://t.co/7GzrfPsGTe
September 14th 2019, 7:09pm
ThisLincolnian @ThisLincolnian
Intra-Cellular Therapies’ $ITCI “Buy” Rating Reaffirmed at Leerink Swann https://t.co/yl2V1MvvNb
September 14th 2019, 7:09pm
stocknewstimes @stocknewstimes
Intra-Cellular Therapies $ITCI Given a $27.00 Price Target by Cantor Fitzgerald Analysts https://t.co/7rGxJ5GqKt
September 14th 2019, 6:09pm
ConsumerFeed @ConsumerFeed
Intra-Cellular Therapies $ITCI Given a $27.00 Price Target by Cantor Fitzgerald Analysts https://t.co/XdeAO7WDrS
September 14th 2019, 6:09pm
TickerReport @TickerReport
Christopher D. Alafi Purchases 485,000 Shares of Intra-Cellular Therapies Inc $ITCI Stock https://t.co/sXNrI2GFoZ
September 14th 2019, 4:09am
Tickeron @Tickeron
$ITCI's 10-day Moving Average broke below its 50-day Moving Average on July 10, 2019. View odds for this and other… https://t.co/mXYmddzUtj
September 14th 2019, 2:09am
TickerReport @TickerReport
Intra-Cellular Therapies $ITCI Earns Buy Rating from Leerink Swann https://t.co/JKrzaq027c
September 13th 2019, 9:09pm
stocknewstimes @stocknewstimes
JMP Securities Reiterates $21.00 Price Target for Intra-Cellular Therapies $ITCI https://t.co/SLVFtKW7l7
September 13th 2019, 11:09am
TranscriptDaily @TranscriptDaily
Intra-Cellular Therapies $ITCI Given a $21.00 Price Target by JMP Securities Analysts https://t.co/hRIeSUyebK
September 13th 2019, 11:09am
dakotafinancial @dakotafinancial
Intra-Cellular Therapies $ITCI Earns Buy Rating from Leerink Swann https://t.co/UCwyByp64R
September 13th 2019, 11:09am
TickerReport @TickerReport
JMP Securities Reiterates $21.00 Price Target for Intra-Cellular Therapies $ITCI https://t.co/GXFOE82MTw
September 13th 2019, 11:09am
ZolmaxNews @ZolmaxNews
Intra-Cellular Therapies $ITCI PT Set at $27.00 by Cantor Fitzgerald https://t.co/sEEOO0xw5i
September 13th 2019, 11:09am
TickerReport @TickerReport
Cantor Fitzgerald Analysts Give Intra-Cellular Therapies $ITCI a $27.00 Price Target https://t.co/Pilc6pvNkG
September 13th 2019, 11:09am
dailypoliticaln @dailypoliticaln
Cantor Fitzgerald Analysts Give Intra-Cellular Therapies $ITCI a $27.00 Price Target https://t.co/7TDUDEb8vO
September 13th 2019, 10:09am
aliontario @aliontario
Bought $itci for a swing
September 13th 2019, 9:09am
StockTexts @StockTexts
$ITCI Intra-Cellular Therapies Inc. SEC Filing: Form EFFECT https://t.co/onAu8Ql3ff
September 13th 2019, 6:09am
confcalltran @confcalltran
Intra-Cellular Therapies Just Received a Notice of Effectiveness https://t.co/Gx2dvgJTD9 $ITCI
September 13th 2019, 6:09am
Tickeron @Tickeron
$ITCI's price moved above its 50-day Moving Average on September 9, 2019. View odds for this and other indicators:… https://t.co/Qg77twFmmn
September 12th 2019, 11:09pm
newswelldone @newswelldone
$ITCI: Intra-Cellular files $350M mixed shelf: https://t.co/AubRB89UVU
September 12th 2019, 6:09pm
LanderJesse @LanderJesse
RT @zbiotech: $ITCI files 350M mixed shelf https://t.co/b6MhvXlBMX
September 12th 2019, 5:09pm
Gambiste1 @Gambiste1
RT @MarketCurrents: $ITCI - Intra-Cellular files $350M mixed shelf https://t.co/InnmfHBQoF
September 12th 2019, 5:09pm
zbiotech @zbiotech
$ITCI files 350M mixed shelf https://t.co/b6MhvXlBMX
September 12th 2019, 5:09pm
MarketCurrents @MarketCurrents
$ITCI - Intra-Cellular files $350M mixed shelf https://t.co/InnmfHBQoF
September 12th 2019, 5:09pm
Stock_News_Now @Stock_News_Now
$ITCI: New SEC Filing for ITCI: Form 424B3 (No. 0001193125-19-243984): https://t.co/SxSY0UATP2
September 12th 2019, 5:09pm
confcalltran @confcalltran
Intra-Cellular Therapies just filed a prospectus, suggesting it plans to soon issue some securi https://t.co/iYQKduMnru $ITCI
September 12th 2019, 5:09pm
pnani456 @pnani456
$ITCI H1 2-1-2 up / D1 3-1-2 up since the FDA no ADCOMM news #TheStrat https://t.co/mnA577qyNS
September 12th 2019, 11:09am
Sports_bios @Sports_bios
Two post X'mas PDUFAs - $ITCI 12/27 and $AMRN 12/28 - will they be actually post-X;mas remains to be seen.. could… https://t.co/KwEBAehH97
September 12th 2019, 7:09am
AmericanBanking @AmericanBanking
Cantor Fitzgerald Analysts Give Intra-Cellular Therapies $ITCI a $27.00 Price Target https://t.co/U7ysbovOdA #stocks
September 12th 2019, 2:09am
AmericanBanking @AmericanBanking
Intra-Cellular Therapies $ITCI Given a $21.00 Price Target by JMP Securities Analysts https://t.co/gyl3wtE734 #stocks
September 12th 2019, 2:09am
aistockfinder @aistockfinder
$ITCI https://t.co/iL1OxkZRfh Intra-Cellular_Therapies_Inc. This is a buy, this stock will probably move up. Hedge… https://t.co/71yB64HBXt
September 12th 2019, 1:09am
Gambiste1 @Gambiste1
RT @Tickeron: $ITCI's 10-day Moving Average broke below its 50-day Moving Average on July 10, 2019. View odds for this and other indicators…
September 12th 2019, 12:09am
Tickeron @Tickeron
$ITCI's 10-day Moving Average broke below its 50-day Moving Average on July 10, 2019. View odds for this and other… https://t.co/2lVkvtBg0J
September 12th 2019, 12:09am
AmericanBanking @AmericanBanking
Intra-Cellular Therapies’ $ITCI “Buy” Rating Reaffirmed at Leerink Swann https://t.co/VKv4doCGKJ #stocks
September 11th 2019, 11:09pm
bbnsnews @bbnsnews
Intra-Cellular Therapies $ITCI Given a $21.00 Price Target at JMP Securities https://t.co/NfVaaHENd7
September 11th 2019, 10:09pm
ThisLincolnian @ThisLincolnian
Intra-Cellular Therapies $ITCI Given a $21.00 Price Target at JMP Securities https://t.co/yzqpmLfBhP
September 11th 2019, 10:09pm
IRAMarketReport @IRAMarketReport
Intra-Cellular Therapies $ITCI Given a $27.00 Price Target at Cantor Fitzgerald https://t.co/zn7z02MZfF #markets
September 11th 2019, 10:09pm
chaffeybreeze @chaffeybreeze
Intra-Cellular Therapies $ITCI Given a $27.00 Price Target at Cantor Fitzgerald https://t.co/6L3t8ONdtf #stocks
September 11th 2019, 10:09pm
ConsumerFeed @ConsumerFeed
Intra-Cellular Therapies $ITCI Given Buy Rating at Leerink Swann https://t.co/wAlEGzETey
September 11th 2019, 10:09pm
IRAMarketReport @IRAMarketReport
Intra-Cellular Therapies $ITCI Rating Reiterated by Leerink Swann https://t.co/wW3omHycxH #markets
September 11th 2019, 9:09pm
chaffeybreeze @chaffeybreeze
Intra-Cellular Therapies $ITCI Rating Reiterated by Leerink Swann https://t.co/TCQD7M69uG #stocks
September 11th 2019, 9:09pm
dakotafinancial @dakotafinancial
Cantor Fitzgerald Reiterates “$27.00” Price Target for Intra-Cellular Therapies $ITCI https://t.co/fGwIFxl48B
September 11th 2019, 9:09pm
WatchlistN @WatchlistN
Intra-Cellular Therapies $ITCI Rating Reiterated by Leerink Swann https://t.co/mAkInz6NFh
September 11th 2019, 9:09pm
ZolmaxNews @ZolmaxNews
Intra-Cellular Therapies $ITCI PT Set at $21.00 by JMP Securities https://t.co/yi8RCePB1B
September 11th 2019, 9:09pm
dailypoliticaln @dailypoliticaln
Intra-Cellular Therapies $ITCI PT Set at $21.00 by JMP Securities https://t.co/ammZNQmZCG
September 11th 2019, 9:09pm
stocknewstimes @stocknewstimes
Christopher D. Alafi Acquires 485,000 Shares of Intra-Cellular Therapies Inc $ITCI Stock https://t.co/9dXtH0OCnP
September 11th 2019, 6:09pm
TranscriptDaily @TranscriptDaily
Intra-Cellular Therapies Inc $ITCI Director Christopher D. Alafi Buys 485,000 Shares https://t.co/ywgfaNBx3e
September 11th 2019, 6:09pm
TheMarketsDaily @TheMarketsDaily
Intra-Cellular Therapies Inc $ITCI Director Christopher D. Alafi Buys 485,000 Shares https://t.co/9Oj5FC7DQk
September 11th 2019, 6:09pm
AmericanBanking @AmericanBanking
Intra-Cellular Therapies Inc $ITCI Director Christopher D. Alafi Buys 485,000 Shares https://t.co/nZRBhV8SFK #stocks
September 11th 2019, 6:09pm
confcalltran @confcalltran
Major owner of Intra-Cellular Therapies just picked up 485,000 shares https://t.co/QSfzyy5p8T $ITCI
September 11th 2019, 4:09pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.